3316
B. A. Trofimov et al. / Tetrahedron Letters 50 (2009) 3314–3317
R2
-
R2
R2
R1
R1
R1
R1
O-
-OH
O
HC CH
LiOH/CsF/DMSO
R2
-CH2
+
N
N
N
N
-H2O
O
B
HO
O
A
R1
N
R1
N
R1
Me
R3
R1
R2
CH/-OH
HC
R2
R2
O
R2
O
N
H
N
C
HO
R3
R3
B
Me
Me
D
Scheme 2.
pressure of 14 atm and then decompressed to atmospheric pressure to remove
air. The autoclave was charged with acetylene again at a pressure of 14 atm and
heated (80 °C) whilst rotating for 60 min. The reaction mixture, after cooling to
room temperature, was diluted with water (100 mL) and extracted with diethyl
ether (20 mL Â 5). The combined extract was washed with cold water
(20 mL Â 3) and dried (K2CO3) overnight. After removal of the solvent,
inone analog of the muscarinic agonist pilocarpine is used for the
treatment of glaucoma.15 Other oxazolidinones are strong agonists
of a
7 nicotinic receptors (a therapy for Alzheimer’s disease).16
In fact, 4-methylene-3-oxa-1-azabicyclo[3.1.0]hexanes 9–15
are novel heterocyclic systems in which the exocyclic double bond
is conjugated both with the oxygen atom and the aziridine ring.
The combination of the three pharmacologically and synthetically
important functional groups (aziridine, 1,3-oxazolidine, and enol
ether) in one molecule may impart to these heterocyclic systems
new properties uncommon for each functionality alone.
In conclusion, a three-component reaction between alkyl-
aryl(hetaryl)ketoximes, acetylene, and aliphatic ketones in the
presence of the superbases LiOH/CsF/DMSO and KOH/DMSO which
affords the novel heterocycles, 4-methylene-3-oxa-1-azabicy-
clo[3.1.0]hexanes, has been reported. The LiOH/CsF/DMSO super-
base catalyzes the reaction with greater selectively. Being readily
available from easily accessible and cheap starting materials, 4-
methylene-3-oxa-1-azabicyclo[3.1.0]hexanes have potential in
drug design and as building blocks for organic synthesis.
620 mg of
a crude residue was obtained. Column chromatography (basic
Al2O3, benzene or hexene) gave 473 mg (75% yield) of 12 as white crystals (mp
136–137 °C). 1H NMR (400.13 MHz, CDCl3): d 8.48 (d, 1H, J = 9.0 Hz, Hpyr), 8.25–
8.15 (m, 4H, Hpyr), 8.13 (d, 1H, J = 9.0 Hz, Hpyr), 8.10–8.00 (m, 3H, Hpyr), 4.43 (d,
1H, J = 2.0 Hz, HB), 3.83 (d, 1H, J = 2.0 Hz, HA), 2.58 (s, 1H, H2), 2.28 (s, 1H, H1),
1.77 (s, 3H, Me), 1.63 (s, 3H, Me). 13C NMR (101.61 MHz, CDCl3): d 159.5 (C4),
132.0–123.1 (16 Cpyr), 99.0 (C2), 86.1 (@CH2), 51.5 (C5), 36.6 (C6), 28.1, 22.7
(2Me). IR (KBr) mmax: 1667, 1460, 1371, 1289, 1226, 1093, 1075, 1036, 1003,
988, 960, 843, 829, 821, 808, 798, 756, 721, 681, 621. Anal. Calcd for C23H19NO
(325.40): C, 84.89; H, 5.89; N, 4.30. Found: C, 85.01; H, 5.99; N, 4.11.
Compounds 10, 11, and 13–15 were obtained analogously.
2,2-Dimethyl-4-methylene-5-phenyl-3-oxa-1-azabicyclo[3.1.0]hexane 10: Oil. 1H
NMR (400.13 MHz, CDCl3): d 7.44 (m, 2H, Ho), 7.35 (m, 2H, Hm), 7.31 (m, 1H,
Hp), 4.42 (d, 1H, J = 1.7 Hz, HB), 3.88 (d, 1H, J = 1.7 Hz, HA), 2.21 (s, 1H, H1), 2.10
(s, 1H, H2), 1.56 (s, 3H, Me), 1.47 (s, 3H, Me). 13C NMR (101.61 MHz, CDCl3): d
160.4 (C4), 135.9 (Ci), 129.0 (Co), 128.5 (Cm), 128.2 (Cp), 98.9 (C2), 85.0 (@CH2),
52.2 (C5), 34.6 (C6), 28.2, 22.6 (2Me). IR (film) mmax: 2989, 2933, 1678, 1500,
1448, 1385, 1372, 1285, 1226, 1152, 1087, 1027, 1005, 963, 850, 821, 755, 698,
531. Anal. Calcd for C13H15NO (201.26): C, 77.58; H, 7.51; N, 6.96. Found: C,
77.71; H, 7.69; N, 6.90.
2,2-Dimethyl-4-methylene-5-(2-naphthyl)-3-oxa-1-azabicyclo[3.1.0]hexane 11:
White crystals (mp 89–92 °C). 1H NMR (400.13 MHz, CDCl3): d 7.90–7.80 (m,
4H, Hnaphth), 7.56 (m, 1H, Hnaphth), 7.47 (m, 2H, Hnaphth), 4.45 (d, 1H, J = 1.8 Hz,
HB), 3.91 (d, 1H, J = 1.8 Hz, HA), 2.32 (s, 1H, H1), 2.19 (s, 1H, H2), 1.62 (s, 3H,
Me), 1.50 (s, 3H, Me). 13C NMR (101.61 MHz, CDCl3): d 160.3 (C4), 133.4–126.3
(10 Cnaphth), 99.1 (C2), 85.3 (@CH2), 52.5 (C5), 34.9 (C6), 28.3, 22.6 (2Me). IR
Acknowledgments
This work has been carried out under financial support of lead-
ing scientific schools by the President of the Russian Federation
(Grant NSH-263.2008.3) and Russian Foundation for Basic Re-
search (Grants 07-03-92162-PICS and 08-03-00002).
(KBr) mmax: 2987, 2931, 1678, 1633, 1505, 1452, 1434, 1380, 1370, 1291, 1224,
1188, 1144, 1126, 1087, 1063, 1001, 984, 967, 952, 914, 870, 844, 808, 750,
696, 523, 478. Anal. Calcd for C17H17NO (251.32): C, 81.24; H, 6.82; N, 5.57.
Found: C, 81.43; H, 7.00; N, 5.41.
2,2-Dimethyl-4-methylene-5-(2-thienyl)-3-oxa-1-azabicyclo[3.1.0]hexane 13: Oil.
1H NMR (400.13 MHz, CDCl3): d 7.26 (dd, 1H, J = 5.2 Hz, J = 1.1 Hz, H5’), 7.09
(dd, 1H, J = 3.6 Hz, J = 1.1 Hz, H3’), 6.97 (dd, 1H, J = 5.2 Hz, J = 3.6 Hz, H4’), 4.51
(d, 1H, J = 1.9 Hz, HB), 4.16 (d, 1H, J = 1.9 Hz, HA), 2.39 (s, 1H, H1), 2.17 (s, 1H,
H2), 1.51 (s, 3H, Me), 1.43 (s, 3H, Me). 13C NMR (101.61 MHz, CDCl3): d 159.3
(C4), 139.2 (C2’), 127.4 (C3’), 127.0 (C4’), 126.0 (C5’), 98.8 (C2), 85.4 (@CH2),
References and notes
1. (a) Trofimov, B. A. Adv. Heterocycl. Chem. 1990, 51, 177–301; (b) Trofimov, B. A.
The Synthesis, Reactivity, and Physical Properties of Substituted Pyrroles; Wiley:
New York, 1992. pp. 131–298; (c) Mikhaleva, A. I.; Schmidt, E. Yu.. In Selected
Methods for Synthesis and Modification of Heterocycles; IBS Press: Moscow, 2002;
Vol. 1, pp 334–352.
47.6 (C5), 36.4 (C6), 27.9, 22.5 (2Me). IR (film) mmax: 2926, 2854, 1653, 1459,
2. (a) Trofimov, B. A.; Schmidt, E. Yu.; Mikhaleva, A. I.; Zorina, N. V.; Ushakov, I. A.;
1375, 1282, 1225, 1152, 1107, 920, 831, 815, 736, 700. Anal. Calcd for
C11H13NOS (207.29): C, 63.74; H, 6.32; N, 6.76; S, 15.47. Found: C, 63.75; H,
6.37; N, 6.71; S 15.30.
´
Afonin, A. V.; Vasiltsov, A. M. Mendeleev Commun. 2007, 17, 40–42; (b)
Trofimov, B. A.; Schmidt, E. Yu.; Zorina, N. V.; Senotrusova, E. Yu.; Protsuk, N. I.;
Ushakov, I. A.; Mikhaleva, A. I.; Méallet-Renault, R.; Clavier, G. Tetrahedron Lett.
2008, 49, 4362–4365.
6-tert-Butyl-2,2-dimethyl-4-methylene-5-(2-thienyl)-3-oxa-1-azabicyclo[3.1.0]-
hexane 14: Oil. 1H NMR (400.13 MHz, CDCl3):
d 7.21 (dd, 1H, J = 5.2 Hz,
3. Trofimov, B. A.; Mikhaleva, A. I.; Vasil’tsov, A. M.; Schmidt, E. Yu.; Tarasova, O.
A.; Morozova, L. V.; Sobenina, L. N.; Preiss, T.; Henkelmann, J. Synthesis 2000,
1125–1132.
4. Trofimov, B. A.; Korostova, S. E.; Mikhaleva, A. I.; Sobenina, L. N.; Sherbakov, V.
V.; Sigalov, M. V. Khim. Geterotsikl. Soed. 1983, 2, 276.
J = 1.1 Hz, H5’), 7.05 (dd, 1H, J = 3.4 Hz, J = 1.1 Hz, H3’), 6.97 (dd, 1H, J = 5.2 Hz,
J = 3.4 Hz, H4’), 4.36 (d, 1H, J = 2.0 Hz, HB), 4.08 (d, 1H, J = 2.0 Hz, HA), 1.97 (s,
1H, H1), 1.54 (s, 3H, Me), 1.46 (s, 3H, Me), 0.78 (s, 9H, t-Bu). 13C NMR
(101.61 MHz, CDCl3): d 160.8 (C4), 138.9 (C2’), 127.4 (C3’), 126.9 (C4’), 125.8
(C5’), 99.4 (C2), 83.5 (@CH2), 55.8 (C6), 52.4 (C5), 31.6 (C-Me3), 27.6 (C-Me3),
5. (a) Trofimov, B. A.; Shevchenko, S. G.; Korostova, S. E.; Mikhaleva, A. I.;
Sherbakov, V. V. Khim. Geterotsikl. Soed. 1985, 11, 1573–1574; (b) Trofimov, B.
A.; Shevchenko, S. G.; Korostova, S. E.; Mikhaleva, A. I.; Sigalov, M. V.; Krivdin, L.
B. Khim. Geterotsikl. Soed. 1989, 11, 1566–1567.
28.3, 22.1 (2Me). IR (film) mmax: 2962, 2927, 2870, 1639, 1385, 1364, 1287,
1169, 1150, 1002, 887, 849, 832, 700. Anal. Calcd for C15H21NOS (263.39): C,
68.40; H, 8.04; N, 5.32; S, 12.17. Found: C, 68.45; H, 7.97; N, 5.19; S 11.99.
2-tert-Butyl-2-methyl-4-methylene-5-(2-thienyl)-3-oxa-1-azabicyclo[3.1.0]-
hexane 15: Oil. 1H NMR (400.13 MHz, CDCl3): d 7.21 (dd, 1H, J = 5.4, J = 1.2 Hz,
H5’), 7.10 (dd, 1H, J = 3.7 Hz, J = 1.2 Hz, H3’), 6.94 (dd, 1H, J = 5.4 Hz, J = 3.7 Hz,
H4’), 4.38 (d, 1H, J = 2.0 Hz, HB), 4.03 (d, 1H, J = 2.0 Hz, HA), 2.45 (s, 1H, H1), 2.12
(s, 1H, H2), 1.31 (s, 3H, Me), 1.00 (s, 9H, t-Bu). 13C NMR (101.61 MHz, CDCl3): d
161.3 (C4), 139.4 (C2’), 127.5 (C3’), 126.8 (C4’), 125.4 (C5’), 105.8 (C2), 81.5
(=CH2), 49.4 (C5), 37.7 (C6), 40.4 (C-Me3), 25.9 (C-Me3), 18.3 (Me). IR (film)
6. Synthesis of 2,2-dimethyl-4-methylene-5-(1-pyrenyl)-3-oxa-1-azabicyclo[3.1.0]-
hexane (12):
A mixture of CsF (293 mg, 1.93 mmol) and LiOH (46 mg,
1.93 mmol) in MeOH (3.0 mL) was stirred at rt for 30 min. Then 1-(1-
pyrenyl)-1-ethanone oxime (500 mg, 1.93 mmol) in DMSO (50 mL) was
added, and the mixture was distilled (80 °C) with stirring until the MeOH
was removed. Next, a vacuum (2 mmHg) at 55 °C was applied to make sure that
the mixture was free from MeOH and H2O. The suspension thus obtained was
placed into a 0.25 L steel rotating autoclave and acetone (112 mg, 1.93 mmol)
in DMSO (5 mL) was added. The autoclave was charged with acetylene at a
m
max: 2961, 2923, 2875, 1673, 1639, 1598, 1394, 1364, 1284, 1172, 1149, 1018,
975, 889, 855, 832, 811, 705. Anal. Calcd for C14H19NOS (249.37): C, 67.43; H,
7.68; N, 5.62; S, 12.86. Found: C, 67.61; H, 7.80; N, 5.44; S 12.78.